Management and Treatment of Kidney and Ureteral Stone
Published: 2020-07-28
Page: 74-85
Issue: 2020 - Volume 3 [Issue 1]
Pranesh Pandurang Memane
Department of Pharmacology, PDEA’S Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune, 412301, India.
Sayali Sunil Chavan
Department of Pharmacology, PDEA’S Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune, 412301, India.
Nayana Bhikaji Mirke
Department of Pharmacology, PDEA’S Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune, 412301, India.
Pradnya Nilesh Jagtap *
Department of Pharmacology, PDEA’S Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune, 412301, India.
*Author to whom correspondence should be addressed.
Abstract
Kidney and ureteral stone are common trouble worldwide with substantial morbidities and economic costs. This review describes focusing on management and treatments of stones. Most ureteral stones can be observed with a reasonable expectation of uneventful stone passage. When an active ureteral stone treatment is warranted, the best procedure to choose is dependent on several factors like stone size and location, patient's preference, available equipment and related costs. Current trends in extracorporeal shockwave lithotripsy (ESWL),percutaneous nephrolithotomy (PCNL) and ureterorenoscopy (URS). ESWL was recommended as the first-line treatment for small and intermediate-sized stones in the lower pole, URS and PCNL is recommended in large size stone treatment. Alpha-blockers are commonly used to improve stone passage through so-called medical expulsive therapy (MET). Immunosuppressive medications and calcium channel blocker use in medical therapy for distal ureteral lithiasis.In the management of kidney stones 2-3 lit/day fluid intake ensures the avoidance of kidney stones formation. Dietary modifications, lifestyle changes, and medical management are essential. This review focuses on management and treatment of kidney and ureteral stones.
Keywords: Kidney stone, urolithiasis, nephrolithiasis, renal calculi.